Type of studies etc. [Dissolution / BCS / IVIVC]

posted by nvs – India, 2008-02-19 08:11 (6697 d 15:31 ago) – Posting: # 1621
Views: 4,265
(edited on 2008-02-19 21:46)

Dear all,
Anybody let me know about flow for in-vitro studies, In which stage of drug designing we have to take approval for in-vitro studies for both innovative & generic drugs.
Which parameters we have to do?
Do we conduct in-vitro studies separately with different mechanism (different in-vitro parameters) for generic & innovative drugs.
What are the common parameters for generic & innovative drugs (in in-vitro studies)
pz share any guidelines regarding this.

--
Edit: Category changed. [Ohlbe]
Edit: Subject line altered. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
115 visitors (0 registered, 115 guests [including 9 identified bots]).
Forum time: 00:43 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5